Frazier Healthcare Partners has announced the closing of its first dedicated public life sciences fund. Frazier Life Sciences Public Fund is closing on nearly $830 million in capital commitments, which exceeds its target. It is a long-only fund that will invest in small- and mid-cap public biotech companies....By: McGuireWoods LLP.